|
Oncology, Other
Contributing journals to this collection:
JAMA & Archives Journals
Citations 491-500 of 652 total displayed.
- Books, Journals, New Media
Oncology: Tumors and Treatment—A Photographic History, 1845-1945
- Harold J. Burstein
JAMA 2004; 292: 2521-2522.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Chemicals Linked to Bladder Cancer in Smokers May Play Wider Role
- Tracy Hampton
JAMA 2004; 292: 2072.
[Extract]
[Full text]
[PDF]
- Reviews
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
- Thomas G. Roberts Jr; Bernardo H. Goulart; Lee Squitieri; Sarah C. Stallings; Elkan F. Halpern; Bruce A. Chabner; G. Scott Gazelle; Stan N. Finkelstein; Jeffrey W. Clark
JAMA 2004; 292: 2130-2140.
[Abstract]
[Full text]
[PDF]
- Editorials
Risks and Benefits of Phase 1 Clinical Trials Evaluating New Anticancer Agents: A Case for More Innovation
- Eric X. Chen; Ian F. Tannock
JAMA 2004; 292: 2150-2151.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Researchers Use Dots to Light Up Tumor Cells
- Tracy Hampton
JAMA 2004; 292: 1944-1945.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Nanotechnology and Cancer
- Tracy Hampton
JAMA 2004; 292: 1946-b.
[Extract]
[Full text]
[PDF]
- Original Articles
Circulating Messenger RNA of  -Fetoprotein: A Possible Risk Factor of Recurrence After Resection of Hepatocellular Carcinoma
- Kuo-Shyang Jeng; I-Shyan Sheen; Yi-Chun Tsai
Arch Surg 2004; 139: 1055-1060.
[Abstract]
[Full text]
[PDF]
- Letters
Disparities in Participation in Cancer Clinical Trials—Reply
- Vivek H. Murthy; Harlan M. Krumholz; Cary P. Gross
JAMA 2004; 292: 922-a-923-a.
[Extract]
[Full text]
[PDF]
- Letters
Disparities in Participation in Cancer Clinical Trials
- Nina H. Bjarnason
JAMA 2004; 292: 922.
[Extract]
[Full text]
[PDF]
- Contempo Updates
Modulating Angiogenesis: More vs Less
- Branavan Sivakumar; Lorraine E. Harry; Ewa M. Paleolog
JAMA 2004; 292: 972-977.
[Abstract]
[Full text]
[PDF]
|
Advertisement
|
|
|
